Stanford University
Showing 28,851-28,900 of 36,308 Results
-
David Shim
Ph.D. Student in Electrical Engineering, admitted Autumn 2024
Current Research and Scholarly InterestsComputer Architecture, Robust Computing, Formal Verification, Machine Learning
-
Haein Shim
Introsems Course Support, Freshman and Sophomore Programs (FSP)
Ida Content Intern, Institute for Diversity in the Arts
Undergraduate, Vice Provost for Undergraduate EducationBioHaein Shim is an activist, documentary producer, journalist, and photojournalist, dedicated to women’s rights and to pursuing truth and social justice through the power of visual storytelling.
Her over 50 published bylines have appeared in numerous international media outlets including TIME, The Economist, NPR, and Vice. Shim has also appeared to provide expert commentary on women’s rights issues in South Korea on global news platforms such as CNN, The Guardian, and Al Jazeera English. Her story as a feminist activist challenging beauty standards can be found in journalist Elise Hu’s book Flawless: Lessons in Looks and Culture from the K-Beauty Capital. Her feminist artwork “I’m Not a Doll, I’m a Person” was selected for the Hallyu! The Korean Wave exhibition, and has been displayed at the Victoria and Albert Museum in London, the Museum of Fine Arts in Boston, the Asian Art Museum in San Francisco, and in its current display at the National Museum of Australia.
In 2023, she was a guest lecturer in a webinar at GADIP (Gender and Development in Practice) in Sweden titled “Gender in South Korea: Antifeminist Backlash and the Recent Rise of Feminist Politics of Refusal.” In 2024, she was invited to speak at Guerrilla in South Korea, where her lecture centered on the importance of women’s higher education. She was an Executive Board Member of Communications for the National Women’s Political Caucus San Gabriel Valley from 2023 to 2024, and was honored with the Women’s March Foundation’s Woman of the Year Award in 2024.
As a photojournalist, she has covered the largest women’s strike in Austria, an anti-femicide conference with DACH Vernetzungswochenende, the Feminist Perspectives Film Forum, and Pride Parade in Vienna. She has worked as an official photographer for film festivals including the Sarajevo Film Festival, International Cinematographers’ Film Festival Manaki Brothers, Drim Short Film Festival, and Ohrid Beach Film Festival, photographing actors Stellan Skarsgård and Willem Dafoe, and cinematographers Darius Khondji and Wally Pfister. At Stanford, she has photographed high-profile events featuring comedian Hasan Minhaj, author Melissa Febos, poets Joy Harjo, Aracelis Girmay, and Hanif Abdurraqib, U.S. Representative Ro Khanna, and U.S. Senator Bernie Sanders.
Currently, Shim is working as a documentary producer with an award-winning Austrian production team, focusing on global femicide across 12 countries. She has worked as an Undergraduate Researcher at the Clayman Institute for Gender Research at Stanford University and as a researcher for the upcoming book Herlands: Lessons From Societies Where Women Make the Rules by Megha Mohan, the BBC’s first Gender and Identity Correspondent.
Shim graduated summa cum laude from Pasadena City College in 2023 and is currently pursuing her undergraduate degree at Stanford University, where she was awarded the 2024–2025 Institute for Diversity in the Arts fellowship as a filmmaker and photographer.
Shim is a proud first-generation immigrant from Gwangju, South Korea, deeply connected to the survivors of the Gwangju Uprising. She is the first woman in her family to pursue higher education. -
Hiroyuki Shimada
Professor of Pathology and, by courtesy, of Pediatrics
BioHiroyuki Shimada, MD, PhD, FRCPA (Hon), is Professor of Pathology and of Pediatrics at the Stanford University Medical Center. He was born in Tokyo, Japan, and completed MD (1973) and PhD (1982) at the Yokohama City University School of Medicine, Yokohama, Japan, and also completed his pathology training at the Children's Hospital (now the Nationwide Children’s Hospital) and the Ohio State University, Columbus, Ohio, USA (1988). Before moving to the Stanford University in 2019, he was Professor of Pathology (Clinical Scholar) at the University of Southern California Keck School of Medicine and working at the Children’s Hospital Los Angeles.
Dr. Shimada was Chair of the International Neuroblastoma Pathology Committee (1999-2017) and the founder of the International Neuroblastoma Pathology Classification (INPC). As Director of the COG (Children’s Oncology Group) Neuroblastoma Pathology Reference Laboratory (since 2001), he has been actively reviewing pathology samples of ~700 neuroblastoma cases per year from United States, Canada, Australia, and New Zealand. Pathology review results according to the INPC have been providing critical information for patient stratification and protocol assignment in the COG international neuroblastoma clinical trials. -
Andrew Young Shin
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsSURF PROGRAM
The SURF program is an innovative collaboration between LPCH, Stanford University Hospital and the Stanford School of Engineering. The program has focused on improving quality and safety of patient care, improving hospital operations and promoting clinical effectiveness utilizing contemporary technologies such as machine learning, mathematical optimization, simulation and a variety of statistical, probabilistic and computational tools. The program has 2 independent funding mechanism to primarily improve patient care/hospital operations and improve academics for faculty within the department of Pediatrics at LPCH.
https://surf.stanford.edu/
CLINICAL EFFECTIVENESS
The Clinical Effectiveness (CE) Program is a funded program that aims to understand and improve unnecessary variation in healthcare delivery in order to optimize quality of care and reduce wasteful expenditures. The CE program has developed innovative programs such as Target Based Care, an award-winning intervention to reduce variation in hospital length of stay and currently a multi-center trial involving more than 20 hospitals in North America. In 2016, the CE program included the first CE fellowship program in a pediatric training program with 3 cycles of graduates. The CE program is supported by LPCH and a philanthropic gift by Susan Choe and Thomas Tobiason. -
Chungheon Shin
Research Engineer
BioChungheon Shin is the Research Director of the Codiga Resource Recovery Center at Stanford University. His work focuses on advancing sustainability through resource recovery from waste streams, with the goal of enabling engineering solutions that recover valuable resources while mitigating greenhouse gas emissions. He has developed and optimized innovative treatment processes that integrate biological and physicochemical systems across multiple scales, ranging from reaction kinetics to systems-level analysis, supported by both conventional and data-driven computational models.
He received his Ph.D. in Environmental Engineering from Inha University in South Korea, where he developed the Staged Anaerobic Fluidized-bed Membrane Bioreactor (SAF-MBR) for the recovery of clean water and energy from municipal wastewater, working with Professor Jaehoe Bae and Professor Perry L. McCarty. He subsequently served as a postdoctoral scholar in the Department of Civil and Environmental Engineering at Stanford University under the supervision of Professor Craig S. Criddle. -
Dongjae Shin
Postdoctoral Scholar, Photon Science, SLAC
BioMy current research focuses on the design of catalytic materials. I have studied atomistic phenomena on catalytic surfaces to develop materials with improved catalytic capability under the philosophy of rational design. To achieve this goal, I use computational approaches, e.g., first-principles calculations and artificial intelligence (AI). Applications include heterogeneous catalysis for exhaust emission control, hydrogen production, and utilization of emission gas to realize carbon neutralization.
-
Gi-Wook Shin
William J. Perry Professor, Senior Fellow at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of East Asian Languages and Cultures
Current Research and Scholarly InterestsKorean democratization; Korean nationalism; U.S.-Korea relations; North Korean politics; reconciliation and cooperation in Northeast Asia; global talent; multiculturalism; inter-Korean relations
-
Rizwan Hassan Shinwari
Visiting Instructor, Neurosurgery
BioRizwan Hassan Shinwari is a Visiting Instructor in the Department of Neurosurgery at Stanford University. His research focuses on the clinical outcomes and adverse effects associated with stereotactic radiosurgery, with the goal of optimizing patient care and advancing neurosurgical precision.
Dr. Shinwari earned his medical degree from Khyber Medical College and brings a strong background in clinical medicine and surgical sciences. His academic and professional interests lie at the intersection of neurosurgery, radiological innovation, and patient-centered outcomes research. He aspires to further his training and career as a neurosurgeon in the United States. -
Josh Shiode
Managing Director, KIPAC
BioJosh Shiode is Managing Director of the Kavli Institute for Particle Astrophysics and Cosmology (KIPAC), a joint institute of Stanford University and the SLAC National Laboratory. Prior to joining KIPAC, Josh served as Senior Advisor and Chief of Staff in the U.S. Department of Energy Office of Science, under the leadership of then Director Asmeret Asefaw Berhe. Josh received his PhD in astrophysics from UC Berkeley in 2013, and subsequently worked in a variety of science and technology policy roles in Washington, DC, including with the American Association for the Advancement of Science and the Pacific Northwest National Laboratory.
-
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation-Cell Therapy (BMT-CT) at Stanford University. The focus of my laboratory research is the exploration of safe and more accessible forms of cell therapy for myeloid malignancies. We are studying multi-antigen targeting antibodies and engineered Natural Killer cells for myeloid malignancies.
